PKC inhibition is involved in trichosanthin-induced apoptosis in human chronic myeloid leukemia cell line K562

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 1, 2007, Pages 63-70

  Li, Jie ^a   Xia, Xuechun ^a   Nie, Huiling ^a   Smith, Mark A ^b   Zhu, Xiongwei ^b  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Apoptosis; Calcium; Caspase 3; PKC; Trichosanthin

Indexed keywords

CALPHOSTIN C; CASPASE 3; TRICHOSANTHIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL TYPE; CHELATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL;

APOPTOSIS; CALCIUM; CALCIUM SIGNALING; CASPASE 3; FLOW CYTOMETRY; HUMANS; MICROSCOPY, CONFOCAL; NAPHTHALENES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; REACTIVE OXYGEN SPECIES; TRICHOSANTHIN;

EID: 33845528947     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.07.011     Document Type: Article

References (36)

1. Shaw P.C., Lee K.M., and Wong K.B. Recent advances in trichosanthin, a ribosome-inactivating protein with multiple pharmacological properties. Toxicon 45 (2005) 683-689
2. Zhang J.S., and Liu W.Y. The mechanism of action of trichosanthin on eukaryotic ribosomes-RNA N-glycosidase activity of the cytotoxin. Nucleic Acids Res. 20 (1992) 1271-1275
3. Xia X., Hou F., Li J., and Nie H. Ribosomal protein L10a, a bridge between trichosanthin and the ribosome. Biochem. Biophys. Res. Commun. 336 (2005) 281-286
4. Zhang C., Gong Y., Ma H., An C., Chen D., and Chen Z.L. Reactive oxygen species involved in trichosanthin-induced apoptosis of human choriocarcinoma cells. Biochem. J. 355 (2001) 653-661
5. Dou C.M., and Li J.C. Effect of extracts of trichosanthes root tubers on HepA-H cells and HeLa cells. World J. Gastroenterol. 10 (2004) 2091-2094
6. Bi L., Li H., and Zhang Y. Effect of trichosanthin of cell cycle and apoptosis of murine melanoma cells. Zhongguo Zhong Xi Yi Jie He Za Zhi 18 (1998) 35-37
7. Li F., Mei Y., Wang Y., Chen C., Tu J., Xiao B., and Xu L. Trichosanthin inhibits antigen-specific T cell expansion through nitric oxide-mediated apoptosis pathway. Cell. Immunol. 234 (2005) 23-30
8. Wang Y.Y., Ouyang D.Y., Huang H., Chan H., Tam S.C., and Zheng Y.T. Enhanced apoptotic action of trichosanthin in HIV-1 infected cells. Biochem. Biophys. Res. Commun. 331 (2005) 1075-1080
9. Herr I., and Debatin K.M. Cellular stress response and apoptosis in cancer therapy. Blood 98 (2001) 2603-2614
10. Friesen C., Fulda S., and Debatin K.M. Cytotoxic drugs and the CD95 pathway. Leukemia 13 (1999) 1854-1858
11. Kim R., Tanabe K., Uchida Y., Emi M., Inoue H., and Toge T. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. Cancer Chemother. Pharmacol. 50 (2002) 343-352
12. Zimmermann K.C., Bonzon C., and Green D.R. The machinery of programmed cell death. Pharmacol. Ther. 92 (2001) 57-70
13. Gutcher I., Webb P.R., and Anderson N.G. The isoform-specific regulation of apoptosis by protein kinase C. Cell. Mol. Life Sci. 60 (2003) 1061-1070
14. Bakalova R., Ohba H., Zhelev Z., Kubo T., Fujii M., Ishikawa M., Shinohara Y., and Baba Y. Atypical protein-kinase Czeta, but neither conventional Ca2+-dependent protein-kinase C isoenzymes nor Ca2+-calmodulin, participates in regulation of telomerase activity in Burkitt's lymphoma cells. Cancer Chemother. Pharmacol. 54 (2004) 161-172
15. Kawatani M., Simizu S., Osada H., Takada M., Arber N., and Imoto M. Involvement of protein kinase C-regulated ceramide generation in inostamycin-induced apoptosis. Exp. Cell Res. 259 (2000) 389-397
16. Al-Rabia M.W., Blaylock M.G., Sexton D.W., and Walsh G.M. Membrane receptor-mediated apoptosis and caspase activation in the differentiated EoL-1 eosinophilic cell line. J. Leukocyte Biol. 75 (2004) 1045-1055
17. Lee W.R., Shen S.C., Lin H.Y., Hou W.C., Yang L.L., and Chen Y.C. Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca(2+)-dependent endonuclease. Biochem. Pharmacol. 63 (2002) 225-236
18. Kaul R., Mukherjee S., Ahmed F., Bhat M.K., Chhipa R., Galande S., and Chattopadhyay S. Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice. Int. J. Cancer 103 (2003) 606-615
19. Chen C.Y., Liou J., Forman L.W., and Faller D.V. Differential regulation of discrete apoptotic pathways by Ras. J. Biol. Chem. 273 (1998) 16700-16709
20. Pettitt T.R., Martin A., Horton T., Liossis C., Lord J.M., and Wakelam M.J. Diacylglycerol and phosphatidate generated by phospholipases C and D, respectively, have distinct fatty acid compositions and functions. Phospholipase D-derived diacylglycerol does not activate protein kinase C in porcine aortic endothelial cells. J. Biol. Chem. 272 (1997) 17354-17359
21. Kong M., Ke Y.B., Zhou M.Y., Ke X.Y., Lu B., and Nie H.L. Study on Trichosanthin induced apoptosis of leukemia K562 cells. Shi Yan Sheng Wu Xue Bao 31 (1998) 233-243
22. Zhang C.Y., Gong Y.X., Ma H., An C.C., and Chen D.Y. Trichosanthin induced calcium-dependent generation of reactive oxygen species in human choriocarcinoma cells. Analyst 125 (2000) 1539-1542
23. Dai R.X., Xu G.J., Lin X.Y., Liu L.Y., Shen H.P., Zhou X.G., Gao T., and Wang Y.H. Studies on injury-mechanism of trichosanthin on trophoblast cells and choriocarcinoma cells in culture. Shi Yan Sheng Wu Xue Bao 26 (1993) 411-427
24. Dirks R.P., Jansen H.J., Gerritsma J., Onnekink C., and Bloemers H.P. Localization and functional analysis of DNase-I-hypersensitive sites in the human c-sis/PDGF-B gene transcription unit and its flanking regions. Eur. J. Biochem. 211 (1993) 509-519
25. Bedard K., MacDonald N., Collins J., and Cribb A. Cytoprotection following endoplasmic reticulum stress protein induction in continuous cell lines. Basic Clin. Pharmacol. Toxicol. 94 (2004) 124-131
26. Drew L., Kumar R., Bandyopadhyay D., and Gupta S. Inhibition of the protein kinase C pathway promotes anti-CD95-induced apoptosis in Jurkat T cells. Int. Immunol. 10 (1998) 877-889
27. Jarvis W.D., Turner A.J., Povirk L.F., Traylor R.S., and Grant S. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res. 54 (1994) 1707-1714
28. Kelly M.L., Tang Y., Rosensweig N., Clejan S., and Beckman B.S. Granulocyte-macrophage colony-stimulating factor rescues TF-1 leukemia cells from ionizing radiation-induced apoptosis through a pathway mediated by protein kinase Calpha. Blood 92 (1998) 416-424
29. Murray N.R., and Fields A.P. Atypical protein kinase C iota protects human leukemia cells against drug-induced apoptosis. J. Biol. Chem. 272 (1997) 27521-27524
30. Lu Y., Jamieson L., Brasier A.R., and Fields A.P. NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival. Oncogene 20 (2001) 4777-4792
31. Tenzer A., Zingg D., Rocha S., Hemmings B., Fabbro D., Glanzmann C., Schubiger P.A., Bodis S., and Pruschy M. The phosphatidylinositide 3′-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C. Cancer Res. 61 (2001) 8203-8210
32. Huigsloot M., Tijdens R.B., and van de Water B. Inhibition of protein kinase Calpha enhances anticancer agent-induced loss of anchorage-independent growth regardless of protection against apoptosis by Bcl-2. Mol. Pharmacol. 64 (2003) 965-973
33. Hanauske A.R., Sundell K., and Lahn M. The role of protein kinase C-alpha (PKC-alpha) in cancer and its modulation by the novel PKC-alpha-specific inhibitor aprinocarsen. Curr. Pharm. Des. 10 (2004) 1923-1936
34. Carter C.A. Protein kinase C as a drug target: implications for drug or diet prevention and treatment of cancer. Curr. Drug Targets 1 (2000) 163-183
35. Kobayashi E., Nakano H., Morimoto M., and Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159 (1989) 548-553
36. Cataldi A., Rapino M., Centurione L., Sabatini N., Grifone G., Garaci F., and Rana R. NF-kappaB activation plays an antiapoptotic role in human leukemic K562 cells exposed to ionizing radiation. J. Cell. Biochem. 89 (2003) 956-963